Sailer C, Pauletzki J, Klueppelberg U G, Fischer S, Sackmann M, Paumgartner G
Dept. of Medicine II, University of Munich, Germany.
Scand J Gastroenterol. 1996 May;31(5):512-6. doi: 10.3109/00365529609006774.
Although it has been shown that chronic administration of ursodeoxycholic acid increases gallbladder fasting and residual volume, it is unknown whether ursodeoxycholic acid exerts an acute effect on gallbladder volume. We therefore evaluated the effect of a single oral dose of ursodeoxycholic acid on gallbladder volume in healthy volunteers.
After the volunteers had fasted overnight, gallbladder volume was measured sonographically every 15 min for 5 h. Following a 1-h control period group I (n = 8) received ursodeoxycholic acid (1000 mg) orally with 100 ml of water, whereas group II (n = 8) received 100 ml of water (placebo) only. Gallbladder volumes were calculated, applying the sum-of-cylinders method. Serum levels of ursodeoxycholic acid were determined by gas chromatography at 1-h intervals.
Gallbladder fasting volumes before ursodeoxycholic acid were similar in both groups (24.0 +/- 2.3 ml versus 25.4 +/- 3.3 ml; NS). After ingestion of ursodeoxycholic acid (group I) gallbladder volume increased rapidly, reaching 27.6 +/- 3.1 ml (p < 0.04) 1 h and 38.4 +/- 3.4 ml (p < 0.02) 4 h after ingestion of ursodeoxycholic acid. The individual gallbladder volumes after ingestion of ursodeoxycholic acid in group I increased to 146%-211% of pretreatment values. Ursodeoxycholic acid serum levels increased from 0.94 +/- 0.38 mumol/l to 10.51 +/- 1.36 mumol/l (p < 0.001) and correlated closely with gallbladder volumes (r = 0.80; p < 0.05). After ingestion of water only (group II) gallbladder volume decreased transiently from 15 min to 30 min after water intake and then remained at pretreatment values throughout the study period.
Administration of a single oral dose of ursodeoxycholic acid causes a rapid increase in gallbladder volume, which reaches 163 +/- 10% of pretreatment volume at 4 h and is closely correlated with ursodeoxycholic acid serum levels.
尽管已有研究表明,长期服用熊去氧胆酸会增加胆囊空腹容积和残余容积,但熊去氧胆酸对胆囊容积是否有急性影响尚不清楚。因此,我们评估了单次口服熊去氧胆酸对健康志愿者胆囊容积的影响。
志愿者过夜禁食后,每隔15分钟用超声测量胆囊容积,共测量5小时。在1小时的对照期后,第一组(n = 8)口服1000毫克熊去氧胆酸并同时饮用100毫升水,而第二组(n = 8)仅饮用100毫升水(安慰剂)。采用圆柱体求和法计算胆囊容积。每隔1小时用气相色谱法测定血清熊去氧胆酸水平。
两组在服用熊去氧胆酸前的胆囊空腹容积相似(分别为24.0±2.3毫升和25.4±3.3毫升;无显著差异)。服用熊去氧胆酸后(第一组),胆囊容积迅速增加,在服用熊去氧胆酸后1小时达到27.6±3.1毫升(p < 0.04),4小时达到38.4±3.4毫升(p < 0.02)。第一组服用熊去氧胆酸后的个体胆囊容积增加到预处理值的146% - 211%。血清熊去氧胆酸水平从0.94±0.38微摩尔/升升至10.51±1.36微摩尔/升(p < 0.001),且与胆囊容积密切相关(r = 0.80;p < 0.05)。仅饮用清水后(第二组),胆囊容积在饮水后15分钟至30分钟短暂下降,然后在整个研究期间维持在预处理值水平。
单次口服熊去氧胆酸会使胆囊容积迅速增加,4小时时达到预处理容积的163±10%,且与血清熊去氧胆酸水平密切相关。